Current understanding of precursors to pancreatic cancer

被引:41
|
作者
Takaori, Kyoichi [1 ]
机构
[1] Osaka Med Coll, Dept Gen & Gastroenterol Surg, Osaka 5698686, Japan
来源
关键词
PanIN (pancreatic intraepithelial neoplasia); IPMN (intraductal papillary mucinous neoplasm); MCN (mucinous cystic neoplasm); carcinoma in situ; carcinogenesis;
D O I
10.1007/s00534-006-1165-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Precursors to pancreatic cancer have been investigated for a century. Previous studies have revealed three distinct precursors, i.e. mucinous cystic neoplasm (MCN), intraductal papillary mucinous neoplasm (IPMN), and pancreatic intraepithelial neoplasia (PanIN), harboring identical or similar genetic alterations as does invasive pancreatic carcinoma. The current understanding of precursors to pancreatic cancer can be illustrated by progressive pathways from noninvasive MCN, IPMN, and PanIN toward invasive carcinoma. MCNs consist of ovarian-type stroma and epithelial lining with varying grades of atypia, and are occasionally associated with invasive adenocarcinoma. The epithelium of noninvasive IPMNs shows a variety of different directions of differentiation, including gastric, intestinal, pancreatobiliary (PB), and oncocytic types. IPMNs can also harbor varying grades of architectural and cytologic atypia. IPMNs confined to branch ducts are mostly the gastric type, and IPMNs involving the main ducts are often intestinal type, while PB and oncocytic types are rare. Small (< 1 cm) IPMNs of the gastric type are not always morphologically distinguishable from low-grade PanINs. Mucin expression profiles suggest intestinal-type IPMNs progress to mucinous noncystic (colloid) carcinoma, while PB-type IPMNs progress toward ductal adenocarcinoma. It is a well-described paradigm that PanIN lesions progress toward ductal adenocarcinoma through step-wise genetic alterations. The activation of Hedgehog and Notch signaling pathways in PanIN lesions as well as in pancreatic adenocarcinoma suggest that developmental pathways may be disregulated during carcinogenesis of the pancreas. Further study is needed to elucidate the pathways from precursors toward invasive carcinoma of the pancreas.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 50 条
  • [41] Current standards of surgery for pancreatic cancer
    Alexakis, N
    Halloran, C
    Raraty, M
    Ghaneh, P
    Sutton, R
    Neoptolemos, JP
    BRITISH JOURNAL OF SURGERY, 2004, 91 (11) : 1410 - 1427
  • [42] Current systemic treatment for pancreatic cancer
    Springfeld, Christoph
    Krug, Sebastian
    Neoptolemos, John
    Jaeger, Dirk
    ONKOLOGIE, 2023, 29 (09): : 769 - 777
  • [43] Current status of pancreatic cancer with oligometastasis
    Chapa-Azuela, Oscar
    Corona-Torres, Maria J.
    Ayala-Moreno, Edwin A.
    Arroyo-Paredes, Paola S.
    Perez-Torres, Eduardo
    Rodriguez-Baez, Alejandro
    Montalvo-Jave, Eduardo E.
    CIRUGIA Y CIRUJANOS, 2023, 91 (02): : 262 - 267
  • [44] Familial Pancreatic Cancer: Current Perspectives
    Llach, Joan
    Carballal, Sabela
    Moreira, Leticia
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 743 - 758
  • [45] Current progress in immunotherapy for pancreatic cancer
    Foley, Kelly
    Kim, Victoria
    Jaffee, Elizabeth
    Zheng, Lei
    CANCER LETTERS, 2016, 381 (01) : 244 - 251
  • [46] The current state of surgery for pancreatic cancer
    Poruk, K. E.
    Weiss, M. J.
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2015, 61 (02) : 101 - 115
  • [47] Current Immunotherapeutic Approaches in Pancreatic Cancer
    Koido, Shigeo
    Homma, Sadamu
    Takahara, Akitaka
    Namiki, Yoshihisa
    Tsukinaga, Shintaro
    Mitobe, Jimi
    Odahara, Shunichi
    Yukawa, Toyokazu
    Matsudaira, Hiroshi
    Nagatsuma, Keisuke
    Uchiyama, Kan
    Satoh, Kenichi
    Ito, Masaki
    Komita, Hideo
    Arakawa, Hiroshi
    Ohkusa, Toshifumi
    Gong, Jianlin
    Tajiri, Hisao
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011,
  • [48] Current status of inherited pancreatic cancer
    Marek Olakowski
    Łukasz Bułdak
    Hereditary Cancer in Clinical Practice, 20
  • [49] Current Standards in the Treatment of Pancreatic Cancer
    Pelzer, Uwe
    Riess, Hanno
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (24) : 1813 - 1816
  • [50] Current immunotherapeutic strategies in pancreatic cancer
    Plate, Janet M. D.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 16 (04) : 919 - +